Deals interview with Mike Preston of Cleary Gottlieb: Oncology is driving healthcare M&As
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData’s deals database. US-based law…
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData’s deals database. US-based law…
UK healthcare company Myovant Sciences has announced positive results from LIBERTY 2, its second Phase III study of relugolix combination…